Pérez, A. I. R., Pedrosa, M. A., Labandeira, C. M., Valenzuela, R., Quijano, A., Sanchez-Andrade, M., . . . Labandeira-García, J. L. (2023). AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. Elsevier.
Dyfyniad Arddull ChicagoPérez, Ana Isabel Rodríguez, María A. Pedrosa, Carmen M. Labandeira, Rita Valenzuela, Aloia Quijano, Mariña Sanchez-Andrade, Juan Antonio Suárez-Quintanilla, Jose Lanciego, and José Luis Labandeira-García. AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. Elsevier, 2023.
Dyfyniad MLAPérez, Ana Isabel Rodríguez, et al. AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. Elsevier, 2023.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.